{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Broomfield",
      "address_1": "2555 W Midway Blvd",
      "reason_for_recall": "Cross Contamination With Other Products: presence of unrelated ingredients (i.e. traces of Lisinopril, Mannitol, Iron, Calcium and Phosphorous).",
      "address_2": "",
      "product_quantity": "11,680 bottles",
      "code_info": "Lot #: GW8264, HD3095, Exp 12/18",
      "center_classification_date": "20180416",
      "distribution_pattern": "Nationwide in the USA and Puerto Rico",
      "state": "CO",
      "product_description": "Triamterene and Hydrochlorothiazide Tablets, USP, 75 mg/50 mg, 500-count bottles, Rx only, Manufactured by Sandoz, Inc., Princeton, NJ 08540, NDC 0781-5067-05.",
      "report_date": "20180425",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Sandoz Incorporated",
      "recall_number": "D-0631-2018",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "79788",
      "termination_date": "20190408",
      "more_code_info": "",
      "recall_initiation_date": "20180406",
      "postal_code": "80020-1632",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}